More
    Guided Solutions - Connecting Talent With Innovation/div>

    Funding

    Vaxess rebrands to Terrestrial Bio, raises $50M for GLP-1 patch

    Vaxess Technologies announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing. Boston-based Terrestrial Bio rebranded to reflect its strategic...

    Endogenex raises $50M to advance type 2 diabetes treatment

    Endogenex has raised $50m in funding, setting the company up with sufficient funds to complete a pivotal trial of its type 2 diabetes (T2D)...

    Hyperfine secures $40M loan facility

    Horizon Technology Finance Corporation said that it provided a $40 million loan facility to Hyperfine. The loan facility includes an initial funding of $15...

    Bioliberty raises $10.2M to scale its AI-powered post-acute care platform

    Bioliberty, a healthtech startup transforming the delivery of physical and occupational therapy, announced that it raised $10.2 million financing. The funds will enable the...

    Imperative Care secures $100M for stroke care tech commercialization

    Imperative Care announced that it closed an oversubscribed convertible note financing totaling $100 million. New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing...

    Monteris Medical raises $28M Series E for robotic neurosurgery tech

    Monteris Medical has closed a $28 million Series E equity financing round as it continues to advance its robotic minimally invasive neurosurgery technology. Minnetonka, Minnesota–based...

    XCath raises $30M Series C to support endovascular robot

    XCath announced that it secured $30 million in its Series C financing round to support its endovascular robotic technology. Crescent Enterprises and Dr. Fred Moll,...

    Chinese ultrasound-based BCI startup Gestala raises $21.7M

    Gestala, a China-based deep-tech startup developing brain-computer interface (BCI) technology, announced $21.69 million in funding. The funding came through an Angel Round and set a...

    Vitestro raises $70M to fuel blood-drawing robot’s global commercial readiness

    Vitestro has raised $70m to advance development and broaden the commercialisation of its autonomous blood-drawing robot. The Dutch company’s oversubscribed Series B financing round saw...
    123...123Page 1 of 123

    Latest articles

    Popular articles

    Featured

    Newsletter

    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    © Copyright - Guided Solutions - Global Executive Search in Medical Devices